These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 32310294)
1. Novel whole-body magnetic resonance imaging response and remission criteria document diminished inflammation during golimumab treatment in axial spondyloarthritis. Krabbe S; Eshed I; Sørensen IJ; Møller J; Jensen B; Madsen OR; Klarlund M; Pedersen SJ; Østergaard M Rheumatology (Oxford); 2020 Nov; 59(11):3358-3368. PubMed ID: 32310294 [TBL] [Abstract][Full Text] [Related]
2. Whole-body Magnetic Resonance Imaging Inflammation in Peripheral Joints and Entheses in Axial Spondyloarthritis: Distribution and Changes during Adalimumab Treatment. Krabbe S; Eshed I; Sørensen IJ; Jensen B; Møller JM; Balding L; Madsen OR; Pedersen SJ; Østergaard M J Rheumatol; 2020 Jan; 47(1):50-58. PubMed ID: 30936290 [TBL] [Abstract][Full Text] [Related]
3. Whole-body Magnetic Resonance Imaging in Axial Spondyloarthritis: Reduction of Sacroiliac, Spinal, and Entheseal Inflammation in a Placebo-controlled Trial of Adalimumab. Krabbe S; Østergaard M; Eshed I; Sørensen IJ; Jensen B; Møller JM; Balding L; Madsen OR; Asmussen K; Eng G; Jørgensen NR; Pedersen SJ J Rheumatol; 2018 May; 45(5):621-629. PubMed ID: 29449506 [TBL] [Abstract][Full Text] [Related]
4. Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial. van der Heijde D; Sieper J; Maksymowych WP; Lambert RG; Chen S; Hojnik M; Anderson JK; Pangan AL Arthritis Res Ther; 2018 Mar; 20(1):61. PubMed ID: 29587851 [TBL] [Abstract][Full Text] [Related]
5. Brief Report: Six-Week Treatment of Axial Spondyloarthritis Patients With an Optimal Dose of Nonsteroidal Antiinflammatory Drugs: Early Response to Treatment in Signal Intensity on Magnetic Resonance Imaging of the Sacroiliac Joints. Varkas G; Jans L; Cypers H; Van Praet L; Carron P; Elewaut D; Van den Bosch F Arthritis Rheumatol; 2016 Mar; 68(3):672-8. PubMed ID: 26473982 [TBL] [Abstract][Full Text] [Related]
6. Effect of golimumab and pamidronate on clinical efficacy and MRI inflammation in axial spondyloarthritis: a 48-week open randomized trial. Mok CC; Li OC; Chan KL; Ho LY; Hui PK Scand J Rheumatol; 2015; 44(6):480-6. PubMed ID: 26271141 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis. Sieper J; van der Heijde D; Dougados M; Maksymowych WP; Scott BB; Boice JA; Berd Y; Bergman G; Curtis S; Tzontcheva A; Huyck S; Weng HH Arthritis Rheumatol; 2015 Oct; 67(10):2702-12. PubMed ID: 26139307 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trial. Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Freundlich B; Lange E; Rudwaleit M; Sieper J Semin Arthritis Rheum; 2016 Feb; 45(4):404-10. PubMed ID: 26519007 [TBL] [Abstract][Full Text] [Related]
9. Structural changes in the sacroiliac joint on MRI and relationship to ASDAS inactive disease in axial spondyloarthritis: a 2-year study comparing treatment with etanercept in EMBARK to a contemporary control cohort in DESIR. Maksymowych WP; Claudepierre P; de Hooge M; Lambert RG; Landewé R; Molto A; van der Heijde D; Bukowski JF; Jones H; Pedersen R; Szumski A; Vlahos B; Dougados M Arthritis Res Ther; 2021 Jan; 23(1):43. PubMed ID: 33514428 [TBL] [Abstract][Full Text] [Related]
10. Axial involvement in patients with early peripheral spondyloarthritis: a prospective MRI study of sacroiliac joints and spine. Renson T; Carron P; De Craemer AS; Deroo L; de Hooge M; Krabbe S; Jans L; Chen M; Østergaard M; Van den Bosch FE; Elewaut D Ann Rheum Dis; 2021 Jan; 80(1):103-108. PubMed ID: 33115761 [TBL] [Abstract][Full Text] [Related]
11. Whole body MRI in spondyloarthritis (SpA): Preliminary results suggest that DWI outperforms STIR for lesion detection. Lecouvet FE; Vander Maren N; Collette L; Michoux N; Triqueneaux P; Stoenoiu M; Houssiau F; Malghem J; Denis ML; Larbi A; Nzeusseu Toukap A Eur Radiol; 2018 Oct; 28(10):4163-4173. PubMed ID: 29666994 [TBL] [Abstract][Full Text] [Related]
12. Relationship between active inflammatory lesions in the spine and sacroiliac joints and new development of chronic lesions on whole-body MRI in early axial spondyloarthritis: results of the ESTHER trial at week 48. Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiss A; Freundlich B; Rudwaleit M; Sieper J Ann Rheum Dis; 2011 Jul; 70(7):1257-63. PubMed ID: 21551507 [TBL] [Abstract][Full Text] [Related]
13. MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation. Maksymowych WP; Wichuk S; Dougados M; Jones H; Szumski A; Bukowski JF; Marshall L; Lambert RG Arthritis Res Ther; 2017 Jun; 19(1):126. PubMed ID: 28587658 [TBL] [Abstract][Full Text] [Related]
14. Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients. Tang M; Xue L; Shen Y; Bo L; Yang R; Wen J; Zhang Y; Liu Z; Fu J Clin Rheumatol; 2018 Jan; 37(1):245-250. PubMed ID: 28497237 [TBL] [Abstract][Full Text] [Related]
15. Validation of whole-body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis. Weber U; Maksymowych WP; Jurik AG; Pfirrmann CW; Rufibach K; Kissling RO; Khan MA; Lambert RG; Hodler J Arthritis Rheum; 2009 Jul; 61(7):893-9. PubMed ID: 19565546 [TBL] [Abstract][Full Text] [Related]
16. Effects of Long-Term Etanercept Treatment on Clinical Outcomes and Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis: 104-Week Results From a Randomized, Placebo-Controlled Study. Dougados M; van der Heijde D; Sieper J; Braun J; Citera G; Lenaerts J; van den Bosch F; Wei JC; Pedersen R; Bonin R; Jones H; Marshall L; Logeart I; Vlahos B; Bukowski JF; Maksymowych WP Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1590-1598. PubMed ID: 28482137 [TBL] [Abstract][Full Text] [Related]
17. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis. van der Heijde D; Sieper J; Maksymowych WP; Brown MA; Lambert RG; Rathmann SS; Pangan AL Arthritis Rheumatol; 2014 Mar; 66(3):667-73. PubMed ID: 24574227 [TBL] [Abstract][Full Text] [Related]
18. Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data. Ruyssen-Witrand A; Luxembourger C; Cantagrel A; Nigon D; Claudepierre P; Degboe Y; Constantin A Arthritis Res Ther; 2019 Jan; 21(1):22. PubMed ID: 30646942 [TBL] [Abstract][Full Text] [Related]
19. Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis. Maksymowych WP; Baraliakos X; Lambert RG; Landewé R; Sandoval D; Carlier H; Lisse J; Li X; Hojnik M; Østergaard M Lancet Rheumatol; 2022 Sep; 4(9):e626-e634. PubMed ID: 38288892 [TBL] [Abstract][Full Text] [Related]
20. Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis? de Hooge M; van den Berg R; Navarro-Compán V; Reijnierse M; van Gaalen F; Fagerli K; Landewé R; van Oosterhout M; Ramonda R; Huizinga T; van der Heijde D Ann Rheum Dis; 2016 Jul; 75(7):1308-14. PubMed ID: 26286018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]